Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. - Wikidata - wikimedia - TriplyDB

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

http://www.wikidata.org/entity/Q34561891

about

Melanoma: from mutations to medicine Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin Hereditary genodermatoses with cancer predisposition Pancreatic cancer.Melanoma genetics.Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO.Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.MC1R genotype may modify the effect of sun exposure on melanoma risk in the GEM study Genetics of familial melanoma: 20 years after CDKN2A.Common susceptibility genes for cancer: search for the end of the rainbow Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.Molecular characteristics of pancreatic ductal adenocarcinoma Histologic features of melanoma associated with CDKN2A genotype.Nonsteroidal anti-inflammatory drugs and risk of melanoma.Vitamin D receptor polymorphisms in patients with cutaneous melanoma Returning individual research results: development of a cancer genetics education and risk communication protocol Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition Melanoma epidemiology.CDKN2A mutations and melanoma risk in the Icelandic population.Selection criteria for genetic assessment of patients with familial melanoma Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone Genetic counseling in melanoma.NF-kappaB activation in melanoma.High- and low-penetrance cutaneous melanoma susceptibility genes.Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.Distance to diagnosing provider as a measure of access for patients with melanoma.High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?Molecular targeted therapies in metastatic melanoma.Issues affecting molecular staging in the management of patients with melanoma Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.Participation bias and its impact on the assembly of a genetic specimen repository for a myocardial infarction cohort Genetic determinants of cutaneous melanoma predisposition.Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.BAP1 and cancer.Management of melanoma families.Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study Insights into melanoma: targeting the mTOR pathway for therapeutics.Current opportunities and challenges: genome-wide association studies on pigmentation and skin cancer.

P2860

Q27024061-62962736-AFAE-4A0B-A6C6-FCC4F37091B9 Q28390768-5BCF9AE6-7D7C-466A-BDAC-60BA4A4E428E Q30470596-8F54CE5A-3621-4D39-80BB-4033F4E12609 Q30490247-73DF9C7C-AF53-43E8-BAB6-DDFBEEB2D93F Q34044830-D1CC1944-C6A2-4F31-8EDE-CA4CFF950BF1 Q34162764-2D89C605-3E49-4451-994C-528F5921E5DE Q34401911-AC66FBC4-0004-4F0B-81F2-6B4FA298D2FF Q34440878-4C9BAF82-A7D7-46C7-AC15-EFC312F827C3 Q34449957-4281F55D-F639-495D-988B-3B717677B8E7 Q34601214-461B2174-4D10-441F-A39B-3F893FF6E3DE Q34694716-0D4A4952-4606-459F-95A2-77453F908734 Q34745252-5705CA41-97C4-4132-B6C2-FEEE914C0252 Q35097007-8484DC62-FE08-4608-8B3D-788382958F94 Q35101863-8BD046A3-E9A8-4FC5-8075-F9FDC44480E9 Q35103696-AC1F95E7-4DB9-44C5-9238-13551D6E623F Q35173889-6C4A37A2-A20B-40CA-87BF-A5CD85F022B5 Q35213835-A86F14A0-E5B5-4A9B-9A44-0A1B17C31AC4 Q35602637-D810C7CE-1AC9-4C07-9C99-9ADBDC9128B4 Q35609672-AEE5EADD-4B7E-4EEB-8FD1-5736C5680810 Q35840024-8158BBEB-D9C6-4470-8AC6-DE11A7F53D0F Q36047747-CB8AB8C1-142F-427C-BF8C-6E9289B871FB Q36055213-65247256-A50E-4441-967B-1659D6C3C0F6 Q36314787-C143CBA4-C98E-407D-8552-F929BC4FC378 Q36416479-5CCD804E-C554-4099-B0D3-6C1E0AFC1F70 Q36499211-D5D11AA0-F709-4269-82A4-714949929907 Q36599686-240F3898-2D2C-4F6E-B210-4294AC088C0F Q36776238-465AC6A1-31B1-4012-937B-152A9482BEB4 Q36808349-9BC02AE0-B7D7-4C0A-BF44-6312A277096F Q36843805-73089BC3-D83A-4CC5-B8EE-ADFABA78D2E8 Q36984179-13B9AED4-4C9C-4439-A868-417D2F8B15A2 Q36990701-192A99CF-553B-4594-BE3C-0F482A8FF2F3 Q37004819-DA58F9BC-9EF5-435E-9FC7-C7915CC89C05 Q37072378-B8A67943-4C82-45C2-9C56-D9E2980A3FF8 Q37137000-EDFE6C57-7FEE-46B0-8542-F2740C5932DC Q37187461-3D143E62-7B62-4862-95D0-411C6D903BFC Q37221089-E23E19F9-8C11-4D75-B516-FE349E64E352 Q37328311-ADEBC186-D4C2-4BC0-A27A-4FA6669B9EBE Q37430032-93E8C736-A18C-46BE-B402-C639A031DEB4 Q38012466-ECA965D8-77DF-4D74-B1F3-A6BC14EF0F51 Q38023900-B795C75F-E8BE-49D7-96E6-DCD9C6DBC64C

P2860

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

http://www.wikidata.org/entity/Q34561891

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@ast

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@en

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@nl

type

label

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@ast

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@en

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@nl

prefLabel

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@ast

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@en

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@nl

P1433

Q34561891-E1189D9E-8C13-456A-AC6B-0B6FB9AA788D

P1476

Q34561891-54029C39-91B1-4ABC-B8CA-D42D7301FF69

P2093

Q34561891-11E2E551-1673-4512-B067-A26C307F313F

Q34561891-137824D1-7645-49A8-BD10-6F69CBE99A8E

Q34561891-14CAFAC6-D988-49A3-87A4-B7A3ABF96A22

Q34561891-15AC6DEF-7EED-4007-9C30-73ECF1589297

Q34561891-303FC8BC-2117-4500-B2AE-0A2E6558B1D0

Q34561891-4036DBF6-B5FE-49A9-936A-A36EDE19100E

Q34561891-49958D14-F598-46E3-ABB3-24A3A706783E

Q34561891-692ADA2B-724F-4B90-B55F-064DC73327B4

Q34561891-840E4553-4F38-4C32-9F2C-10A51C080DAF

Q34561891-9804AB00-671E-4532-BCD2-57572D406F47

P304

Q34561891-9DB77060-F4E3-4CD1-8CC6-924E9261317B

P31

Q34561891-FE52761E-1E91-4C1B-96E7-CC864F4A5231

P356

Q34561891-9181C6CA-61E9-4DF5-8841-BE13651D881A

P407

Q34561891-DB5AE65E-7898-46CF-AA24-A8B74B23B4D1

P433

Q34561891-F4979F14-8CF6-40E2-BD72-6D8EFCF12E89

P478

Q34561891-D3BD3A16-5DBC-418A-849C-D6902F5D293A

P50

Q34561891-188AD014-BDC2-4CAB-90E2-C2FD3FDF3DCD

Q34561891-677B1848-93D2-42E1-9538-4D6245F1D5BC

Q34561891-7DB036A3-1B03-441F-96CD-7810ECD9AB6B

Q34561891-9C6F053D-5EDC-4EDB-A515-CEBAB4FCA09D

Q34561891-C6EA0205-5129-43A2-98AD-73FDF3F44D89

P577

Q34561891-8FEC38FE-AEE9-4453-8445-9EA1F489D7D3

P5875

Q34561891-92859F4B-5CF7-4BF5-A109-B7922E50CFE9

P698

Q34561891-4981F897-6727-48D5-920F-EF4D3FE8BBB5

P356

P1433

Journal of the National Cancer Institute

P1476

Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.

@en

P2093

Amanda J Hummer

http://www.w3.org/2001/XMLSchema#string

Anne Kricker

http://www.w3.org/2001/XMLSchema#string

Colin B Begg

http://www.w3.org/2001/XMLSchema#string

Genes Environment and Melanoma Study Group

http://www.w3.org/2001/XMLSchema#string

Klaus Busam

http://www.w3.org/2001/XMLSchema#string

Loraine D Marrett

http://www.w3.org/2001/XMLSchema#string

Lynn From

http://www.w3.org/2001/XMLSchema#string

Nandita Mitra

http://www.w3.org/2001/XMLSchema#string

Richard P Gallagher

http://www.w3.org/2001/XMLSchema#string

Robert C Millikan

http://www.w3.org/2001/XMLSchema#string

P304

1507-1515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJI312

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Hoda Anton-Culver

Marianne Berwick

Bruce Armstrong

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7531041

http://www.w3.org/2001/XMLSchema#string

P698

16234564

http://www.w3.org/2001/XMLSchema#string